Safety of 25- and 50-mg capsules in the initiation of zonisamide therapy in patients with epilepsy: An uncontrolled, open-label study

Current Medical Research and Opinion

Volumn 20, Issue 6, 2004, Pages 837-842

  Uthman, Basim M ^a,e   Miller, G Steven ^b   Montouris, Georgia ^c   James, Steven P ^d   Anthony, Stacy ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Children's Medical Center   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d ELAN PHARMACEUTICALS   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antiepilepsy drugs; Epilepsy; Titration; Zonisamide

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ABDOMINAL PAIN; ACCIDENT; ADOLESCENT; ADULT; AMNESIA; ANOREXIA; ARTICLE; ASTHENIA; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; CONVULSION; DIARRHEA; DIZZINESS; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EPILEPSY; FEMALE; GRAND MAL EPILEPSY; HEADACHE; HUMAN; INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYOCLONUS; NAUSEA; OPEN STUDY; PHARYNGITIS; PHASE 3 CLINICAL TRIAL; RASH; RHINITIS; SOMNOLENCE; THOUGHT DISORDER; URINARY TRACT INFECTION; VOMITING;

ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; HUMANS; ISOXAZOLES; MALE; UNITED STATES;

EID: 3042616590     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125003629     Document Type: Article

References (13)

1. Zonegran [package insert]. San Diego, Calif: Elan Pharmaceuticals, Inc; 2003
2. Schauf CL. Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res 1987;413:185-8
3. Suzuki S, Kawakami K, Nishimura S, et al. Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex. Epilepsy Res 1992;12:21-7
4. Zhu WT, Rogawski MA. Zonisamide depresses excitatory synaptic transmission by a presynaptic action [abstract]. Epilepsia 1999;7:245
5. Okada M, Hirano T, Kawata Y, et al. Biphasic effects of zonisamide on serotonergic system in rat hippocampus. Epilepsy Res 1999;34:187-97
6. Okada M, Kaneko S, Hirano T, et al. Effects of zonisamide on dopaminergic system. Epilepsy Res 1995;22:193-205
7. Komatsu M, Okamura Y, Hiramatsu M. Free radical scavenging activity of zonisamide and its inhibitory effect on lipid peroxide formation in iron-induced epileptogenic foci of rats. Neurosciences 1995;21:23-9
8. Mori A, Noda Y, Packer L. The anticonvulsant zonisamide scavenges free radicals. Epilepsy Res 1998;30:153-8
9. Endoh A, Kinno I, Kawai M, Hiramatsu M, Mori A. Effects of zonisamide on neurotransmitter in mouse brain. Neurosciences 1994;20:P173-6
10. Kawai M, Endoh A, Kinno I, et al. Effect of zonisamide on release of aspartic acid and gamma-aminobutyric acid from hippocampal slices of E1 mice. Neurosciences 1994;20:115-9
11. Schmidt D, Jacob R, Loiseau P, et al. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res 1993;15:67-73
12. Faught E, Ayala R, Montouris GG, Leppik IE. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 2001;57:1774-9
13. Sackellares JC, Ramsay RE, Wilder BJ, Browne TR III, Shellenberger K. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia: [in press]